【结 构 式】 |
【分子编号】37350 【品名】5-(4-hydroxycyclohexyl)-1,3-dimethyl-1,3,5-triazinan-2-one 【CA登记号】 |
【 分 子 式 】C11H21N3O2 【 分 子 量 】227.30676 【元素组成】C 58.12% H 9.31% N 18.49% O 14.08% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(III)Selective O-alkylation of trans-4-aminocyclohexanol (I) was effected by protection of the amino group as the triazinone (III) upon treatment with N,N-dimethylurea and formaldehyde. Subsequent alkylation of (III) with tert-butyl bromoacetate under phase-transfer conditions afforded ether (IV). The protecting group of (IV) was then removed by treatment with ammonium chloride.
【1】 Ono, S.; Yoshida, T.; Ashimori, A.; Kosaka, K.; Okada, T.; Maeda, K.; Eda, M.; Mori, F.; Inoue, Y.; Ebisu, H.; Imada, T.; Ikegawa, R.; Wang, F.; Nakamura, N. (Welfide Corporation); Novel fused-ring carboxylic acid cpds. or salt thereof,and medicinal use thereof. EP 0712844; JP 1996053398; JP 1996231548; US 5635527; US 5753670; WO 9533720 . |
【2】 Nakamura, N.; Imada, T.; Inoue, Y.; Kosaka, K.; Yoshida, T.; Ono, S.; Fukaya, C.; Maeda, K.; Preparation and pharmacological evaluation of novel glycoprotein (Gp) IIb/IIIa antagonists. 2. Condensed heterocyclic derivatives. Chem Pharm Bull 1999, 47, 12, 1694. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
17430 | 2-Bromoacetic acid tert-butyl ester; tert-butyl 2-bromoacetate; tert-Butyl bromoacetate | 5292-43-3 | C6H11BrO2 | 详情 | 详情 | |
(I) | 19581 | trans-4-Aminocyclohexanol;trans-4-Amino-1-cyclohexanol;trans-4-Amino-1-cyclohexanol; | 27489-62-9 | C6H13NO | 详情 | 详情 |
(II) | 21488 | N,N'-dimethylurea | 96-31-1 | C3H8N2O | 详情 | 详情 |
(III) | 37350 | 5-(4-hydroxycyclohexyl)-1,3-dimethyl-1,3,5-triazinan-2-one | C11H21N3O2 | 详情 | 详情 | |
(IV) | 37351 | tert-butyl 2-[[4-(3,5-dimethyl-4-oxo-1,3,5-triazinan-1-yl)cyclohexyl]oxy]acetate | C17H31N3O4 | 详情 | 详情 | |
(V) | 37352 | tert-butyl 2-[(4-aminocyclohexyl)oxy]acetate | C12H23NO3 | 详情 | 详情 |
Extended Information